Novavax, Inc. (NVAX)
8.70
+0.28
(+3.33%)
USD |
NASDAQ |
Feb 13, 16:00
8.70
0.00 (0.00%)
After-Hours: 17:32
Novavax Free Cash Flow : -384.71M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 13.05B |
| Pfizer Inc. | 10.38B |
| Moderna, Inc. | -2.663B |
| Plus Therapeutics, Inc. | -15.78M |
| INVO Fertility, Inc. | -7.772M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 107.80M |
| Cash from Investing (Quarterly) | -136.53M |
| Cash from Financing (Quarterly) | 42.44M |
| Free Cash Flow Per Share (Quarterly) | 0.6516 |
| Free Cash Flow to Equity (Quarterly) | 83.14M |
| Free Cash Flow to Firm (Quarterly) | 111.25M |
| Free Cash Flow Yield | -26.11% |